MLTH

Latest SEC Filings & News for MLTH

1 most recent filing and news item mentioning MLTH. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/MLTH/news?limit=20"

Pull MLTH filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJun 22, 2026Positive

MapLight Therapeutics releases Phase 2 IRIS trial topline data for ML-004 in autism

MapLight Therapeutics announced topline data from its Phase 2 IRIS trial evaluating ML-004 for autism spectrum disorder treatment. The clinical trial results represent a key milestone in the company's development pipeline for this therapeutic candidate.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.